Myxoma virus and the leporipoxviruses: An evolutionary paradigm

Viruses

Volumn 7, Issue 3, 2015, Pages 1020-1061

  Kerr, Peter J ^a   Liu, June ^a   Cattadori, Isabella ^b   Ghedin, Elodie ^c   Read, Andrew F ^b   Holmes, Edward C ^d  

^a CSIRO   (Australia)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d University of Sydney   (Australia)

Author keywords

Coevolution; Leporipoxvirus; Myxoma virus; Myxomatosis; Poxvirus; Rabbit

Indexed keywords

AUSTRALIA; CHORDOPOXVIRINAE; COEVOLUTION; EUROPE; EVOLUTION; GENOME ANALYSIS; HARE FIBROMA VIRUS; HOST PATHOGEN INTERACTION; HOST RANGE; IMMUNE RESPONSE; LEPORIPOXVIRUS; MOSQUITO; MYXOMA VIRUS; MYXOMATOSIS; NATURAL SELECTION; NONHUMAN; ORYCTOLAGUS CUNICULUS; PHYLOGEOGRAPHY; REVIEW; SPECIES DIFFERENCE; SQUIRREL FIBROMA VIRUS; VIRUS ATTENUATION; VIRUS GENE; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS VIRULENCE; ADAPTATION; ANIMAL; CLASSIFICATION; FRANCE; GENETICS; GENOTYPE; RABBIT; TRANSMISSION; VIROLOGY; VIRULENCE;

ARTHROPODA; CHORDOPOXVIRINAE; DNA VIRUSES; LEPORIDAE; LEPORIPOXVIRUS; MYXOMA VIRUS; ORYCTOLAGUS CUNICULUS; POXVIRIDAE; SCIURIDAE;

ADAPTATION, BIOLOGICAL; ANIMALS; AUSTRALIA; BIOLOGICAL EVOLUTION; FRANCE; GENOTYPE; MYXOMA VIRUS; MYXOMATOSIS, INFECTIOUS; RABBITS; VIRULENCE;

EID: 84925841072     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7031020     Document Type: Review

References (209)

1. Burnet, M. Changing Patterns; Heinemann: Melbourne, Australia, 1968.
2. May, R.M.; Anderson, R.M. Epidemiology and genetics in the coevolution of parasites and hosts. Proc. R. Soc. Lond. B 1983, 219, 281-313.
3. Ratcliffe, F.N.; Myers, K.; Fennessy, B.V.; Calaby, J.H. Myxomatosis in Australia. A step towards the biological control of the rabbit. Nature 1952, 170, 7-19.
4. Myers, K. Studies in the epidemiology of infectious myxomatosis of rabbits. II. Field experiments, August-November 1950, and the first epizootic of myxomatosis in the Riverine plain of south-eastern Australia. J. Hyg. 1954, 52, 47-59.
5. Bull, L.B.; Mules, M.W. An investigation of myxomatosis cuniculi with special reference to the possible use of the disease to control rabbit populations in Australia. J. CSIR 1944, 17, 79-93.
6. Lockley, R.M. Some experiments in rabbit control. Nature 1940, 145, 767-769.
7. Lockley, R.M. Failure of myxomatosis on Skokholm Island. Nature 1955, 175, 906-907.
8. Fenner, F.; Ratcliffe, F.N. Myxomatosis; Cambridge University Press: Cambridge, UK, 1965.
9. Sanarelli, G. Das myxomatogene Virus. Beitrag zum Stadium der Krankheitserreger ausserhalb des Sichtbaren. Zbl. Bakt. 1898, 23, 865-873. (in German)
10. Kilham, L. Metastasizing viral fibromas of gray squirrels: Pathogenesis and mosquito transmission. Am. J. Hyg. 1955, 61, 55-63.
11. Kilham, L.; Herman, C.M.; Fisher, E.R. Naturally occurring fibromas of grey squirrels related to Shope’s rabbit fibroma. Proc. Soc. Exper. Biol. Med. 1953, 82, 298-301.
12. Regnery, D.C.; Marshall, I.D. Studies in the epidemiology of myxomatosis in California. IV. The susceptibility of six leporid species to Californian myxoma virus and the relative infectivity of their tumours for mosquitoes. Am. J. Epidemiol. 1971, 94, 508-513.
13. Karstad, L.; Thorsen, J.; Davies, G.; Kaminjolo, J.S. Poxvirus fibromas on African hares. J. Wildl. Dis. 1977, 13, 245-247.
14. Fenner, F.; Woodroofe, G.M. Protection of laboratory rabbits against myxomatosis by vaccination with fibroma virus. Aust. J. Exptl. Biol. Med. Sci. 1954, 32, 653-668.
15. Marlier, D. Vaccination against myxoma virus infections: Are we really doing the best? Tijdschr. Diergeneeskd. 2010, 135, 194-198.
16. Fenner, F.; Marshall, I.D. A comparison of the virulence for European rabbits (Oryctolagus cuniculus) of strains of myxoma virus recovered in the field in Australia, Europe and America. J. Hyg. 1957, 55, 149-191.
17. Silvers, L.; Inglis, B.; Labudovic, A.; Janssens, P.A.; van Leeuwen, B.H.; Kerr, P.J. Virulence and pathogenesis of the MSW and MSD strains of Californian myxoma virus in European rabbits with genetic resistance to myxoma virus compared to rabbits with no genetic resistance. Virology 2006, 348, 72-83.
18. Woodroofe, G.M.; Fenner, F. Viruses of the myxoma-fibroma subgroup of the poxviruses. I. Plaque production in cultured cells, plaque-reduction tests and cross-protection tests in rabbits. Aust. J. Exptl. Biol. Med. Sci. 1965, 43, 123-142.
19. Fenner, F. Viruses of the myxoma-fibroma subgroup of the poxviruses. II. Comparison of soluble antigens by gel diffusion tests, and a general discussion of the subgroup. Aust. J. Exp. Biol. Med. Sci. 1965, 43, 143-156.
20. Aragão, H.D.B. O virus do mixoma no coelho do mato (Sylvilagus. minensus) sua transmissao pelos Aedes. scapularis e aegypti. Mem. Inst. Oswaldo Cruz 1943, 38, 93-99. (in Portuguese)
21. Howard, W.E.; Amaya, J.N. European rabbit invades western Argentina. J. Wildl. Man.1975, 39, 757-761.
22. Jaksic, F.M.; Yanez, J.L. Rabbit and fox introductions in Tierra del Fuego: History and assessment of the attempts at biological control of the rabbit infestation. Biol. Conserv. 1983, 26, 367-374.
23. Grodhaus, G.; Regnery, D.C.; Marshall, I.D. Studies in the epidemioloy of myxomatosis in California. II. The experimental transmission of myxomatosis between brush rabbits (Sylvilagus bachmani) by several species of mosquitoes. Am. J. Hyg. 1963, 77, 205-212.
24. Marshall, I.D.; Regnery, D.C.; Grodhaus, G. Studies in the epidemiology of myxomatosis in California. I. Observations on two outbreaks of myxomatosis in coastal California and the recovery of myxoma virus from a brush rabbit (Sylvilagus bachmani). Am. J. Hyg. 1963, 77, 195-204.
25. Kessel, J.F.; Prouty, C.C.; Meyer, J.W. Occurence of infectious myxomatosis in southern California. Proc. Soc. Exp. Biol. Med. 1931, 28, 413-414.
26. Kessel, J.F.; Fiskm, R.T.; Prouty, C.C. Studies with the Californian Strain of the Virus of Infectious Myxomatosis. In Proceedings of the Fifth Pacific Science Congress; University of Toronto Press: Toronto, ON, Canada, 1934; pp. 2927-2939.
27. Marshall, I.D.; Regnery, D.C. Myxomatosis in a Californian brush rabbit. Nature 1960, 188, 73-74.
28. Regnery, D.C.; Miller, J.H. A myxoma virus epizootic in a brush rabbit population. J. Wildl. Dis. 1972, 8, 327-331.
29. Patton, N.M.; Holmes, H.T. Myxomatosis in domestic rabbits in Oregon. J. Am. Vet. Assoc. 1977, 171, 560-562.
30. Luna, R.M.L. First report of myxomatosis in Mexico. J. Wildl. Dis. 2000, 36, 580-583.
31. Shope, R.E. A transmissible tumour-like condition in rabbits. J. Exp. Med. 1932, 56, 793-802.
32. Shope, R.E. A filtrable virus causing a tumour-like condition in rabbits and its relationship to virus myxomatosum. J. Exp. Med. 1932, 56, 803-822.
33. Kilham, L.; Woke, P.A. Laboratory transmission of fibromas (Shope) in cottontail rabbits by means of fleas and mosquitoes. Proc. Soc. Exp. Biol. Med. 1953, 83, 296-301.
34. Dalmat, H.T. Arthropod transmission of rabbit fibromatosis (Shope). J. Hyg. 1959, 57, 1-30.
35. Kilham, L.; Dalmat, H.T. Host-virus-mosquito relations of Shope fibromas in cottontail rabbits. Am. J. Hyg. 1955, 61, 45-54.
36. Kilham, L.; Fisher, E.R. Pathogenesis of fibromas in cottontail rabbits. Am. J. Hyg. 1954, 61, 45-54.
37. Yuill, T.M.; Hanson, R.P. Infection of suckling cottontail rabbits with Shope’s fibroma virus. Proc. Soc. Exp. Biol. Med. 1964, 117, 376-380.
38. Joiner, G.N.; Jardine, J.H.; Gleiser, C.A. An epizootic of Shope fibromatosis in a commercial rabbitry. J. Am. Vet. Med. Assoc. 1971, 159, 1583-1587.
39. Raflo, C.P.; Olsen, R.G.; Pakes, S.P.; Webster, W.S. Characterization of a fibroma virus isolated from naturally-occurring skin tumors in domestic rabbits. Lab. Anim. Sci. 1973, 23, 525-532.
40. Arthur, C.P.; Louzis, C. La myxomatose du lapin en France: Une revue. Rev. Sci. Tech. Off. Int. Epiz. 1988, 7, 937-957. (in French)
41. Rogers, P.M.; Arthur, C.P.; Soriguer, R.C. The rabbit in continental Europe. In The European Rabbit The History and Biology of a Successful Colonizer; Thompson, H.V., King, C.M., Eds.; Oxford University Press: Oxford, UK, 1994; pp. 22-63.
42. Fenner, F. Hare fibroma virus. In Virus Infections of Rodents and Lagomorphs; Osterhaus, A.D.M.E., Ed.; Elsevier Science B.V.: Amsterdam, The Netherlands, 1994; Volume 5, pp. 77-79.
43. Micozzi, G.; Palarchi, M. Spontaneous myxomatosis in hares. Vet. Ital. 1965, 26, 361-362.
44. Barlow, A.; Lawrence, K.; Everest, D.; Dastjerdi, A.; Finnegan, C.; Steinbach, F. Confirmation of myxomatosis in a European brown hare in Great Britain. Vet. Rec. 2014, 175, 75-76.
45. Kirschstein, R.L.; Rabson, A.S.; Kilham, L. Pulmonary lesions produced by fibroma viruses in squirrels and rabbits. Cancer Res. 1958, 18, 1340-1344.
46. King, J.M.; Woolf, A.; Shively, J.N. Naturally occurring squirrel fibroma virus with involvement of internal organs. J. Wildl. Dis. 1972, 8, 321-324.
47. Hirth, R.S.; Wyand, D.S.; Osborne, A.D.; Burke, C.N. Epidermal changes caused by squirrel poxvirus. J. Am. Vet. Med. Assoc. 1969, 155, 1120-1125.
48. Novilla, M.N.; Flyger, V.; Jacobson, E.R.; Dutta, S.K.; Sacchi, E.M. Systemic phycomycosis and multiple fibromas in a gray squirrel (Sciurus carolinensis). J. Wildl. Dis. 1981, 17, 89-95.
49. Herman, C.M.; Reilly, J.R. Skin tumors on squirrels. J. Wildl. Man. 1955, 19, 402-403.
50. Regnery, R.L. Preliminary studies on an unusual poxvirus of the western grey squirrel (Sciurus griseus griseus) of North America. Intervirology 1975, 5, 364-366.
51. Martin, C.J. Observations on Myxomatosis cuniculi (Sanarelli) Made with a View to the Use of the Virus in the Control of Rabbit Plagues. C.S.I.R: Melbourne, Australia, 1936.
52. Bull, L.B.; Dickinson, C.G. The specificity of the virus of rabbit myxomatosis. J. CSIR 1937, 10, 291-294.
53. Marshall, I.D.; Regnery, D.C. Studies in the epidemiology of myxomatosis in California. III. The response of brush rabbits (Sylvilagus bachmani) to infection with exotic and enzootic strains of myxoma virus and the relative infectivity of the tumours for mosquitoes. Am. J. Hyg. 1963, 77, 213-219.
54. Regnery, D.C. The epidemic potential of Brazilian myxoma virus (Lausanne strain) for three species of North American cottontails. Am. J. Epidemiol. 1971, 94, 514-519.
55. Day, M.F.; Fenner, F.; Woodroofe, G.M.; McIntyre, G.A. Further studies on the mechanism of mosquito transmission of myxomatosis in the European rabbit. J. Hyg. 1956, 54, 258-283.
56. Dalmat, H.T.; Stanton, M.F. A comparative study of the Shope Fibroma in rabbits in relation to transmissibility by mosquitoes. J. Natl. Cancer Inst. 1959, 22, 593-615.
57. Fenner, F.; Ross, J. Myxomatosis. In The European Rabbit. The History and Biology of a Successful Colonizer; Thompson, H.V., King, C.M., Eds.; Oxford University Press: Oxford, UK, 1994; pp. 205-240.
58. Silvers, L.; Barnard, D.; Knowlton, F.; Inglis, B.; Labudovic, A.; Holland, M.K.; Janssens, P.A.; van Leeuwen, B.A.; Kerr, P.J. Host-specificity of myxoma virus: Pathogenesis of South American and North American strains of myxoma virus in two North American lagomorph species. Vet. Microbiol. 2010, 141, 289-300.
59. Cameron, C.; Hota-Mitchell, S.; Chen, L.; Barrett, J.; Cao, J.-X.; Macaulay, C.; Willer, D.; Evans, D.; McFadden, G. The complete DNA sequence of myxoma virus. Virology 1999, 264, 298-318.
60. Morales, M.; Ramirez, M.A.; Cano, M.J.; Parraga, M.; Castilla, J.; Perez-Ordoyo, L.I.; Torres, J.M.; Barcena, J. Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain. J. Virol. 2009, 83, 2397-2403.
61. Willer, D.O.; McFadden, G.; Evans, D.H. The complete genome sequence of Shope (rabbit) fibroma virus. Virology 1999, 264, 319-343.
62. Kerr, P.J.; Rogers, M.B.; Fitch, A.; Depasse, J.V.; Cattadori, I.M.; Hudson, P.J.; Tscharke, D.C.; Holmes, E.C.; Ghedin, E. Comparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptations. J. Virol. 2013, 87, 12080-12089.
63. Upton, C.; Slack, S.; Hunter, A.L.; Ehlers, A.; Roper, R.L. Poxvirus orthologous clusters: Towards defining the minimal essential poxvirus genome. J. Virol. 2003, 77, 7590-7600.
64. Kerr, P.J. Myxomatosis in Australia and Europe: A model for emerging infectious diseases. Antiviral Res. 2012, 93, 387-415.
65. Allison, A.C. Immune responses to Shope fibroma virus in adult and newborn rabbits. J. Natl. Cancer Inst. 1966, 36, 869-875.
66. Allison, A.C.; Friedman, R.M. Effects of immunosuppressants on Shope rabbit fibroma. J. Natl. Cancer Inst. 1966, 36, 859-868.
67. Sell, S.; Scott, C.B. An immunohistologic study of Shope Fibroma Virus in rabbits: Tumor rejection by cellular reaction in adults and progressive systemic reticuloendothelial infection in neonates. J. Natl. Cancer Inst. 1981, 66, 363-373.
68. Lalani, A.S.; Masters, J.; Graham, K.; Liu, L.; Lucas, A.; McFadden, G. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology 1999, 256, 233-245.
69. Upton, C.; Macen, J.L.; Schreiber, M.; McFadden, G. Myxoma virus expresses a secreted protein with homology to the tumour necrosis factor receptor gene family that contributes to viral virulence. Virology 1991, 184, 370-382.
70. Macen, J.L.; Graham, K.A.; Fong Lee, S.; Schreiber, M.; Boshkov, L.K.; McFadden, G. Expression of the myxoma virus tumour necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology 1996, 218, 232-237.
71. Schreiber, M.; Sedger, L.; McFadden, G. Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. J. Virol. 1997, 71, 2171-2191.
72. Sedger, L.M.; Osvath, S.R.; Xu, X.-M.; Li, G.; Chan, F.K.-M.; Barrett, J.W.; McFadden, G. Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death. J. Virol. 2006, 80, 9300-9309.
73. González, J.M.; Esteban, M. A poxvirus Bcl-2-like gene family involved in regulation of host immune response: Sequence similarity and evolutionary history. Virol. J. 2010, 7, e59.
74. Hnatiuk, S.; Barry, M.; Zeng, W.; Liu, L.; Lucas, A.; Percy, D.; McFadden, G. Role of the C-terminal RDEL motif of the myxoma virus M-T4 protein in terms of apoptosis regulation and viral pathogenesis. Virology 1999, 263, 290-306.
75. Barry, M.; Hnatiuk, S.; Mossman, K.; Lee, S.F.; Boshkov, L.; McFadden, G. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology 1997, 239, 360-377.
76. Mossman, K.; Fong Lee, S.; Barry, M.; Boshkov, L.; McFadden, G. Disruption of M-T5, a novel myxoma virus gene member of the poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J. Virol. 1996, 70, 4394-4410.
77. Zhang, L.; Villa, N.Y.; McFadden, G. Interplay between poxviruses and the cellular ubiquitin/ ubiquitin-like pathways. FEBS Lett. 2009, 583, 607-614.
78. Mossman, K.; Nation, P.; Macen, J.; Garbutt, M.; Lucas, A.; McFadden, G. Myxoma virus M-T7, a secreted homolog of the interferon-γ receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 1996, 215, 17-30.
79. Lalani, A.S.; Graham, K.; Mossman, K.; Rajarathnam, K.; Clark-Lewis, I.; Kelvin, D.; McFadden, G. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J. Virol. 1997, 71, 4356-4363.
80. Macen, J.L.; Upton, C.; Nation, N.; McFadden, G. Serp 1, a secreted proteinase inhibitor encoded by myxoma virus is a secreted glycoprotein that interferes with inflammation. Virology 1993, 195, 348-363.
81. Opgenorth, A.; Graham, K.; Nation, N.; Strayer, D.; McFadden, G. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 1992, 66, 4720-4731.
82. Graham, K.A.; Opgenorth, A.; Upton, C.; McFadden, G. Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virology 1992, 191, 112-124.
83. Johnston, J.B.; Barrett, J.W.; Nazarian, S.H.; Goodwin, M.; Ricuttio, D.; Wang, G.; McFadden, G. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 2005, 23, 587-598.
84. Myskiw, C.; Arsenio, J.; Hammett, C.; van Bruggen, R.; Deschambault, Y.; Beausoleil, N.; Babiuk, S.; Cao, J. Comparative analysis of poxvirus orthologues of the Vaccinia Virus E3 protein: Modulation of PKR activity, cytokine responses and virus pathogenicity. J. Virol. 2011, 85, 12280-12291.
85. Rahman, M.M.; Liu, J.; Chan, W.M.; Rothenburg, S.; McFadden, G. Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host-tropism and viral replication. PLOS Pathog. 2013, 9, e1003465.
86. Schweneker, M.; Lukassen, S.; Spath, M.; Wolferstatter, M.; Babel, E.; Brinkmann, K.; Wielert, U.; Chaplin, P.; Suter, M.; Hausmann, J. The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence. J. Virol. 2012, 86, 2323-2336.
87. Liu, J.; Wennier, S.; Zhang, L.; McFadden, G. M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells. J. Virol. 2011, 85, 3270-3282.
88. Barrett, J.W.; Shun Chang, C.; Wang, G.; Werden, S.J.; Shao, Z.; Barrett, C.; Gao, X.; Belsito, T.A.; Villenevue, D.; McFadden, G. Myxoma virus M063R is a host range gene essential for virus replication in rabbit cells. Virology 2007, 361, 123-132.
89. Liu, J.; Wennier, S.; Moussatche, N.; Reinhard, M.; Condit, R.C.; McFadden, G. Myxoma virus M064 is a novel member of the poxvirus C7L superfamily of host-range factors that controls the kinetics of myxomatosis in European rabbits. J. Virol. 2012, 86, 5371-5375.
90. Cameron, C.M.; Barrett, J.W.; Mann, M.; Lucas, A.; McFadden, G. Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology 2005, 337, 55-67.
91. Barrett, J.W.; Werden, S.J.; Wang, F.; McKillop, W.M.; Jimeneza, J.; Villeneuve, D.; McFadden, G.; Dekaban, G.A. Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbits. Virus Res. 2009, 144, 258-265.
92. Cao, J.X.; Teoh, M.L.T.; Moon, M.; McFadden, G.; Evans, D.H. Leporipoxvirus Cu-Zn superoxide dismutase homologs inhibit cellular superoxide dismutase, but are not essential for virus replication or virulence. Virology 2002, 296, 125-135.
93. Teoh, M.L.T.; Turner, P.V.; Evans, D.H. Tumorigenic poxviruses up-regulate intracellular superoxide to inhibit apoptosis and promote cell proliferation. J. Virol. 2005, 79, 5799-5811.
94. Teoh, M.L.T.; Walasek, P.J.; Evans, D.H. Leporipoxvirus. Cu, Zn-superoxide dismutase (SOD) homologs are catalytically inert decoy proteins that bind copper chaperone for SOD. J. Biol. Chem. 2003, 278, 33175-33184.
95. Barrett, J.W.; Sypula, J.; Wang, F.; Alston, L.R.; Shao, Z.; Gao, X.; Irvine, T.S.; McFadden, G. M135R is a novel cell surface virulence factor of myxoma virus. J. Virol. 2007, 81, 106-114.
96. Moss, B. Poxviridae: The viruses and their replication. In Fields’ Virology, 5th ed.; Knipe, D.M., Howley, P.M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; Volume 2, pp. 2905-2945.
97. Jackson, R.J.; Hall, D.F.; Kerr, P.J. Myxoma virus encodes an α2,3-sialyltransferase that enhances virulence. J. Virol. 1999, 73, 2376-2384.
98. Cameron, C.M.; Barrett, J.W.; Liu, L.; Lucas, A.R.; McFadden, G. Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo. J. Virol. 2005, 79, 6052-6067.
99. Hovey Nerenberg, B.T.; Taylor, J.; Bartee, E.; Gouveia, K.; Barry, M.; Früh, K. The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factories. J. Virol. 2005, 79, 597-601.
100. Brick, D.J.; Burke, R.D.; Schiff, L.; Upton, C. Shope fibroma virus RING finger protein N1R binds DNA and inhibits apoptosis. Virology 1998, 249, 42-51.
101. Blanié, S.; Mortier, J.; Delverdier, M.; Bertagnoli, S.; Camus-Bouclainville, C. M148R and M149R are two virulence factors for myxoma virus pathogenesis in the European rabbit. Vet. Res. 2009, 40, e11.
102. Camus-Bouclainville, C.; Fiette, L.; Bouchiha, S.; Pignolet, B.; Counor, D.; Filipe, C.; Gelfi, J.; Messud-Petit, F. A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation. J. Virol. 2004, 78, 2510-2516.
103. Blanié, S.; Gelfi, J.; Bertagnoli, S.; Camus-Bouclainville, C. MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection. Virol. J. 2010, 7, e56.
104. Messud-Petit, F.; Gelfi, J.; Delverdier, M.; Amardeilh, M.-F.; Py, R.; Sutter, G.; Bertagnoli, S. Serp 2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus. J. Virol. 1998, 72, 7830-7839.
105. Guérin, J.-L.; Gelfi, J.; Camus, C.; Delverdier, M.; Whisstock, J.C.; Amardeihl, M.-F.; Py, R.; Bertagnoli, S.; Messud-Petit, F. Characterization and functional analysis of Serp 3: A novel myxoma virus-encoded serpin involved in virulence. J. Gen. Virol. 2001, 82, 1407-1417.
106. Collin, N.; Guérin, J.-L.; Drexler, I.; Blanié, S.; Gelfi, J.; Boullier, S.; Foucras, G.; Sutter, G.; Messud-Petit, F. The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules. Virology 2005, 343, 171-178.
107. Guérin, J.L.; Gelfi, J.; Boullier, S.; Delverdier, M.; Bellanger, F.A.; Bertagnoli, S.; Drexler, I.; Sutter, G.; Messud-Petit, F. Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins. J. Virol. 2002, 76, 2912-2923.
108. Mansouri, M.; Bartee, E.; Gouveia, K.; Hovey Nerenberg, B.T.; Barrett, J.; Thomas, L.; Thomas, G.; McFadden, G.; Früh, K. The PHD/LAP-domain protein M153R of myxoma virus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD 4. J. Virol. 2003, 77, 1427-1440.
109. Gedey, R.; Jin, X.-L.; Hinthong, O.; Shisler, J.L. Poxviral regulation of the host-NF-κB response: The vaccinia virus M2L protein inhibits induction of NF-κB activation via an ERK2 pathway in virus-infected human embryonic kidney cells. J. Virol. 2006, 80, 8676-8685.
110. Ramelot, T.A.; Cort, J.R.; Yee, A.A.; Liu, F.; Goshe, M.B.; Edwards, A.M.; Smith, R.D.; Arrowsmith, C.H.; Dever, T.E.; Keenedy, M.A. Myxoma virus immunomodulatory protein M156R is a structural mimic of eukaryotic translation initiation factor eIF2α. J. Mol. Biol. 2002, 322, 943-954.
111. Upton, C.; Macen, J.L.; Wishart, D.S.; McFadden, G. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for viral virulence. Virology 1990, 179, 618-631.
112. Fenner, F.; Woodroofe, G.M. The pathogenesis of infectious myxomatosis: The mechanism of infection and the immunological response in the European rabbit (Oryctolagus cuniculus). Br. J. Exp. Pathol. 1953, 34, 400-410.
113. Best, S.M.; Kerr, P.J. Coevolution of host and virus: The pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Virology 2000, 267, 36-48.
114. Best, S.M.; Collins, S.V.; Kerr, P.J. Coevolution of host and virus: Cellular localization of myxoma virus infection of resistant and susceptible European rabbits. Virology 2000, 277, 76-91.
115. Hurst, E.W. Myxoma and the Shope fibroma. I. The histology of myxoma. Br. J. Exp. Pathol. 1937, 18, 1-15.
116. Hobbs, J.R. Studies of the nature of infectious myxoma of rabbits. Am. J. Hyg. 1928, 8, 800-839.
117. Duclos, P.; Tuaillon, P.; Joubert, L. Histopathologie de l’atteinte cutanéo-muqueuse et pulmonaire de la myxomatose. Bull. Acad. Vet. 1983, 56, 95-104. (in French)
118. Marlier, D.; Mainil, J.; Sulon, J.; Beckers, J.F.; Linden, A.; Vindevogel, H. Study of the virulence of five strains of amyxomatous myxoma virus in crossbred New Zealand White/Californian conventional rabbits, with evidence of long-term testicular infection in recovered animals. J. Comp. Path. 2000, 122, 101-113.
119. Spiesschaert, B.; McFadden, G.; Hermans, K.; Nauwynck, H.; van de Walle, G.R. The current status and future directions of myxoma virus, a master in immune evasion. Vet. Res. 2011, 42, 76.
120. Mims, C. Aspects of the pathogenesis of viral diseases. Bacteriol. Rev. 1964, 28, 30-71.
121. Corbet, G.B. Taxonomy and origins. In The European Rabbit. The History and Biology of a Succesful Colonizer; Thompson, H.V., King, C.M., Eds.; Oxford University Press: Oxford, UK, 1994; pp. 1-7.
122. Flux, J.E.C. World distribution. In The European Rabbit. The History and Biology of a Successful Colonizer; Thompson, H.V., King, C.M., Eds.; Oxford University Press: Oxford, UK, 1994; pp. 8-21.
123. Carneiro, M.; Rubin, C.-J.; DiPalma, F.; Albert, F.W.; Alfoldi, J.; Barrio, A.M.; Pielberg, G.; Rafati, N.; Sayyab, S.; Turner-Maier J., et al. Rabbit genome analysis reveals a polygenic basis for phenotypic change during domestication. Science 2014, 345, 1074-1079.
124. Rolls, E.C. They All Ran Wild; Angus and Robertson: Melbourne, Australia, 1969.
125. Cooke, B.D. Rabbits: Manageable environmental pests or participants in new Australian ecosystems? Wildl. Res. 2012, 39, 279-289.
126. Aragão, H.B. Myxoma of rabbits. Mem. Inst. Oswaldo Cruz 1927, 20, 237-247.
127. Fenner, F.; Fantini, B. Biological Control of Vertebrate Pests. The History of Myxomatosis—An Experiment in Evolution; CAB International: New York, NY, USA, 1999.
128. Calaby, J.H.; Gooding, C.D.; Tomlinson, A.R. Myxomatosis in Western Australia. CSIRO Wildl. Res. 1960, 5, 89-101.
129. Williams, K.; Parer, I.; Coman, B.; Burley, J.; Braysher, M. Managing Vertebrate Pests: Rabbits; Bureau of Rural Sciences: Canberra, Australia, 1995.
130. Moses, A. O virus do mixoma dos coelhos. Mem. Instit. Oswaldo Cruz 1911, 3, 46-53. (in Portuguese)
131. Fenner, F. Changes in the mortality rate due to myxomatosis in the Australian wild rabbit. Nature 1953, 172, 228-230.
132. Myers, K.; Marshall, I.D.; Fenner, F. Studies in the epidemiology of infectious myxomatosis of rabbits. III. Observations on two succeeding epizootics in Australian wild rabbits on the Riverine plain of south-eastern Australia. J. Hyg. 1954, 52, 337-360.
133. Marshall, I.D.; Dyce, A.L.; Poole, W.E.; Fenner, F. Studies in the epidemiogy of infectious myxomatosis of rabbits. IV. Observations of disease behaviour in two localities near the northern limit of rabbit infestation in Australia, May 1952 to April 1953. J. Hyg. 1955, 53, 12-25.
134. Fenner, F.; Day, M.F.; Woodroofe, G.M. Epidemiological consequences of the mechanical transmission of myxomatosis by mosquitoes. J. Hyg. 1956, 54, 284-303.
135. Fenner, F.; Woodroofe, G.M. Changes in the virulence and antigenic structure of strains of myxoma virus recovered from Australian wild rabbits between 1950 and 1964. Aust. J. Exp. Biol. Med. Sci. 1965, 43, 359-370.
136. Sampford, M.R. The estimation of response time distribution. III. Truncation and survival. Biometrics 1954, 10, 531-561.
137. Fenner, F. Biological control as exemplified by smallpox eradication and myxomatosis. Proc. R. Soc. Lond. B 1983, 218, 259-285.
138. Saint, K.M.; French, N.; Kerr, P. Genetic variation in Australian isolates of myxoma virus: An evolutionary and epidemiological study. Arch. Virol. 2001, 146, 1105-1123.
139. Kerr, P.J.; Hone, J.; Perrin, L.; French, N.; Williams, C.K. Molecular and serological analysis of the epidemiology of myxoma virus in rabbits. Vet. Microbiol. 2010, 143, 167-178.
140. Fenner, F.; Marshall, I.D.; Woodroofe, G.M. Studies in the epidemiology of infectious myxomatosis of rabbits. I. Recovery of Australian wild rabbits (Oryctolagus. cuniculus) from myxomatosis under field conditions. J. Hyg. 1953, 51, 225-244.
141. Marshall, I.D. The influence of ambient temperature on the course of myxomatosis in rabbits. J. Hyg. 1959, 57, 484-497.
142. Sobey, W.R.; Menzies, W.; Conolly, D.; Adams, K.M. Myxomatosis: The effect of raised ambient temperature on survival time. Aust. J. Sci. 1968, 30, 322-323.
143. Marshall, I.D.; Fenner, F. Studies in the epidemiology of infectious myxomatosis of rabbits. V. Changes in the innate resistance of wild rabbits exposed to myxomatosis. J. Hyg. 1958, 56, 288-302.
144. Marshall, I.D.; Douglas, G.W. Studies in the epidemiology of infectious myxomatosis of rabbits. VIII. Further observations on changes in the innate resistance of Australian wild rabbits exposed to myxomatosis. J. Hyg. 1961, 59, 117-122.
145. Ross, J. Myxomatosis: The natural evolution of the disease. In Animal Disease in Relation to Animal Conservation; Academic Press: London, UK, 1982; Volume 50, pp. 77-92.
146. Kerr, P.J.; Perkins, H.D.; Inglis, B.; Stagg, R.; McLaughlin, E.; Collins, S.V.; van Leeuwen, B.H. Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis. Virology 2004, 324, 117-128.
147. Kerr, P.J.; McFadden, G. Immune responses to myxoma virus. Viral Immunol. 2002, 15, 229-246.
148. Sobey, W.R.; Conolly, D. Myxomatosis: Non-genetic aspects of resistance to myxomatosis in rabbits Oryctolagus cuniculus. Aust. Wildl. Res. 1986, 13, 177-188.
149. Williams, C.K.; Moore, R.J. Inheritance of acquired immunity to myxomatosis. Aust. J. Zool. 1991, 39, 307-312.
150. Parer, I.; Sobey, W.R.; Conolly, D.; Morton, R. Sire transmission of acquired resistance to myxomatosis. Aust. J. Zool. 1995, 43, 459-465.
151. Edmonds, J.W.; Nolan, I.F.; Shephard, R.C.H.; Gocs, A. Myxomatosis: The virulence of field strains of myxoma virus in a population of wild rabbits (Oryctolagus cuniculus L.) with high resistance to myxomatosis. J. Hyg. 1975, 74, 417-418.
152. Parer, I.; Sobey, W.R.; Conolly, D.; Morton, R. Virulence of strains of myxoma virus and the resistance of wild rabbits (Oryctolagus cuniculus L.), from different locations in Australasia. Aust. J. Zool. 1994, 42, 347-362.
153. Anderson, R.M.; May, R.M. Coevolution of hosts and parasites. Parasitology 1982, 85, 411-426.
154. Dwyer, G.; Levin, S.; Buttel, L. A simulation model of the population dynamics and evolution of myxomatosis. Ecol. Monogr. 1990, 60, 423-447.
155. Fenner, F.; Poole, W.E.; Marshall, I.D.; Dyce, A.L. Studies in the epidemiology of infectious myxomatosis of rabbits. VI. The experimental introduction of the European strain of myxoma virus into Australian wild rabbit populations. J. Hyg. 1957, 55, 192-206.
156. Parer, I.; Conolly, D.; Sobey, W.R. Myxomatosis: The effects of annual introductions of an immunizing strain and a highly virulent strain of myxoma virus into rabbit populations at Urana, New South Wales, Australia. Aust. Wildl. Res. 1985, 12, 407-424.
157. Shephard, R.C.H.; Edmonds, J.W. Myxomatosis: Changes in the epidemiology of myxomatosis coincident with the establishment of the European rabbit flea Spilopsyllus cuniculi (Dale) in the mallee region of Victoria. J. Hyg. 1978, 81, 399-403.
158. Berman, D.; Kerr, P.J.; Stagg, R.; van Leeuwen, B.H.; Gonzalez, T. Should the 40-year-old practice of releasing virulent myxoma virus to control rabbits (Oryctolagus cuniculus) be continued? Wildl. Res. 2006, 33, 549-556.
159. Seymour, R.M. A study of the interaction of virulence, resistance and resource limitation in a model of myxomatosis mediated by the European rabbit flea Spilopsyllus cuniculi (Dale). Ecol. Model. 1992, 60, 281-308.
160. Mead-Briggs, A.R.; Vaughan, J.A. The differential transmissibility of myxoma virus strains of differing virulence grades by the rabbit flea Spilopsyllus. cuniculi (Dale). J. Hyg. 1975, 75, 237-247.
161. Mykytowycz, R. The effect of season and mode of transmission on the severity of myxomatosis due to an attenuated strain of the virus. Aust. J. Exp. Biol. Med. Sci. 1956, 34, 121-132.
162. Joubert, L.; Duclos, P.; Toaillen, P. La myxomatose des garennes dans le sud-est. La myxomatose amyxomateuse. Rev. Méd. Vét. 1982, 133, 739-753. (in French)
163. Cattadori, I.M.; Albert, R.; Boag, B. Variation in host susceptibility and infectiousness generated by co-infection: The myxoma-Trichostrongylus retortaeformis case in wild rabbits. J. R. Soc. Interface 2007, 4, 831-840.
164. Thompson, H.V. The rabbit in Britain. In The European Rabbit. The History and Biology of a Successful Colonizer; Thompson, H.V., King, C.M., Eds.; Oxford University Press: Oxford, UK, 1994; pp. 64-107.
165. Lloyd H.G. Post-myxomatosis rabbit populations in England and Wales. EPPO Public. Ser. A 1970, 197-215.
166. Sobey, W.R.; Menzies, W. Myxomatosis: The introduction of the European rabbit flea Spilopsyllus cuniculi (Dale) into Australia. Aust. J. Sci. 1969, 31, 404-405.
167. Cooke, B.D. Changes in the age-structure and size of populations of wild rabbits in South Australia, following the introduction of European rabbit fleas, Spilopsyllus cuniculi (Dale), as vectors of myxomatosis. Aust. Wildl. Res. 1983, 10, 105-120.
168. Cooke, B.D. Notes on the comparative reproductive biology and the laboratory breeding of the rabbit flea Xenopsylla cunicularis Smit (Siphonaptera: Pulicidae). Aust. J. Zool. 1990, 38, 527-534.
169. Joubert, L.; Leftheriotis, E.; Mouchet, J. La Myxomatose; L’expansion Scientifique Francaise: Paris, France, 1972. (in French)
170. Bárcena, J.; Pagès-Manté, A.; March, R.; Morales, M.; Ramírez, M.A.; Sánchez-Vizcaíno, J.M.; Torres, J.M. Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates. Arch. Virol. 2000, 146, 759-771.
171. Fenner, F.; Chapple, P.J. Evolutionary changes in myxoma virus in Britain. An examination of 222 naturally occurring strains obtained from 80 counties during the period October-November 1962. J. Hyg. 1965, 63, 175-185.
172. Ross, J.; Sanders, M.F. Changes in the virulence of myxoma virus strains in Britain. Epidem. Inf. 1987, 98, 113-117.
173. Mead-Briggs, A.R. Some experiments concerning the interchange of rabbit fleas, Spilopsyllus cuniculi (Dale), between living rabbit hosts. J. Anim. Ecol. 1964, 33, 13-26.
174. Ross, J.; Sanders, M.F. Innate resistance to myxomatosis in wild rabbits in England. J. Hyg. 1977, 79, 411-415.
175. Ross, J.; Sanders, M.F. The development of genetic resistance to myxomatosis in wild rabbits in Britain. J. Hyg. 1984, 92, 255-261.
176. Brun, A.; Godard, A.; Moreau, Y. La vaccination contre la myxomatose. Vaccins heterologues et homologues. Bull. Soc. Vet. Med. Comp. 1981, 83, 251-254. (in French)
177. Marlier, D.; Cassart, D.; Boucrat-Baralon, C.; Coignoul, F.; Vindevogel, H. Experimental infection of specific pathogen-free New Zealand white rabbits with five strains of amyxomatous myxoma virus. J. Comp. Path. 1999, 121, 369-384.
178. Marlier, D.; Mainil, J.; Linden, A.; Vindevogel, H. Infectious agents associated with rabbit pneumonia: Isolation of amyxomatous myxoma virus strains. Vet. J. 2000, 159, 171-178.
179. Marlier, D.; Herbots, J.; Detilleux, J.; Lemaire, M.; Thiry, E.; Vindevogel, H. Cross-sectional study of the association between pathological conditions and myxoma virus seroprevalence in intensive rabbit farms in Europe. Prev. Vet. Med. 2001, 48, 55-64.
180. Williams, R.T.; Dunsmore, J.D.; Parer, I. Evidence for the existence of a latent myxoma virus in rabbits Oryctolagus cuniculus (L.). Nature 1972, 238, 99-101.
181. Kritas, S.K.; Dovas, C.; Fortomaris, P.; Petridou, E.; Farsang, A.; Koptopoulos, G. A pathogenic myxoma virus in vaccinated and non-vaccinated commercial rabbits. Res. Vet. Sci. 2008, 85, 622-624.
182. Marlier, D.; Mainil, J.; Boucrat-Baralon, C.; Linden, A.; Vindevogel, H. The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain. J. Comp. Path. 2000, 122, 115-122.
183. Kerr, P.J.; Merchant, J.C.; Silvers, L.; Hood, G.; Robinson, A.J. Monitoring the spread of myxoma virus in rabbit populations in the southern tablelands of New South Wales, Australia. II. Selection of a virus strain that was transmissible and could be monitored by polymerase chain reaction. Epidemiol. Infect. 2003, 130, 123-133.
184. Ferreira, C.; Ramírez, E.; Castro, F.; Ferreras, P.; Alves, P.C.; Redpath, S.; Villafuerte, R. Field experimental vaccination campaigns against myxomatosis and their effectiveness in the wild. Vaccine 2009, 27, 6998-7002.
185. Guitton, J.-S.; Devillard, S.; Guénézan, M.; Fouchet, D.; Pontier, D.; Marchandeau, S. Vaccination of free-living juvenile wild rabbits (Oryctolagus. cuniculus) against myxomatosis improved their survival. Vet. Prev. Med. 2008, 84, 1-10.
186. Saito, J.K.; McKercher, D.G.; Castrucci, G. Attenuation of the myxoma virus and use of the living attenuated virus as an immunizing agent for myxomatosis. J. Infect. Dis. 1964, 114, 417-428.
187. Saurat, P.; Gilbert, Y.; Ganiere, J.-P. Etude d’une souche de virus myxomateux modifée. Rev. Méd. Vét. 1978, 129, 415-451. (in French)
188. Pšikal, I.; Šmid, B.; Rodák, L.; Valíček, L.; Bendová, J. Atypical myxomatosis—Virus isolation, experimental infection of rabbits and restriction endonuclease analysis of the isolate. J. Vet. Med. 2003, B50, 259-264.
189. Camus-Bouclainville, C.; Gretillat, M.; Py, R.; Gelfi, J.; Guérin, J.-L.; Bertagnoli, S. Genome sequence of SG33 strain and recombination between wild-type and vaccine myxoma viruses. Emerg. Inf. Dis. 2011, 17, 633-638.
190. Kerr, P.J.; Rogers, M.B.; Fitch, A.; DePasse, J.V.; Cattadori, I.M.; Twaddle, A.C.; Hudson, P.J.; Tscharke, D.C.; Read, A.F.; Holmes E.C, et al. Genome scale evolution of myxoma virus reveals host pathogen adaptation and rapid geographic spread. J. Virol. 2013, 87, 12900-12915.
191. Strayer, D.S.; Sell, S. Immunohistology of malignant rabbit fibroma virus—A comparative study with rabbit myxoma virus. J. Nalt. Cancer Inst. 1983, 71, 106-116.
192. Block, W.; Upton, C.; McFadden, G. Tumorigenic poxviruses: Genomic organization of malignant rabbit virus a recombinant between Shope fibroma virus and myxoma virus. Virology 1985, 140, 113-124.
193. Upton, C.; Macen, J.L.; Maranchuk, R.A.; Delange, A.M.; McFadden, G. Tumorigenic poxviruses: Fine analysis of the recombination junctions in malignant rabbit fibroma virus a recombinant between Shope fibroma virus and myxoma virus. Virology 1988, 166, 229-239.
194. Berkowitz, E.M.; Pogo, B.G. Molecular characterization of two strains of Shope fibroma virus. Virology 1985, 142, 437-440.
195. Kerr, P.J.; Ghedin, E.; DePasse, J.V.; Fitch, A.; Cattadori, I.M.; Hudson, P.J.; Tscharke, D.C.; Read, A.F.; Holmes, E.C. Evolutionary history and attenuation of myxoma virus on two continents. PLOS Pathog. 2012, 8, e1002950.
196. Firth, C.; Kitchen, A.; Shapiro, B.; Suchard, M.; Holmes, E.C.; Rambaut, A. Using time-stranded data to estimate evolutionary rates of double-stranded DNA viruses. Mol. Biol. Evol. 2010, 27, 2038-2051.
197. Douglas, G.W. The Glenfield strain of myxoma virus. Its use in Victoria. J. Agric. Agric. Vict. 1962, 60, 511-516.
198. Mykytowycz, R. An attenuated strain of the myxomatosis virus recovered from the field. Nature 1953, 172, 448-449.
199. Kerr, P.J.; Jackson, R.J.; Robinson, A.J.; Swan, J.; Silvers, L.; French, N.; Clarke, H.; Hall, D.F.; Holland, M.K. Infertility in female rabbits (Oryctolagus. cuniculus) alloimmunized with the rabbit zona pellucida protein ZPB either as a purified recombinant protein or expressed by recombinant myxoma virus. Biol. Reprod. 1999, 61, 601-613.
200. Alzhanova, D.; Edwards, D.M.; Hammarlund, E.; Scholz, I.G.; Horst, D.; Wagner, M.J.; Upton, C.; Wiertz, E.J.; Slifka, M.K.; Früh, K. Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host Microb. 2009, 6, 4333-4445.
201. Belsham, G.J.; Polacek, C.; Breum, S.Ø.; Larsen, L.E.; Bøtner, A. Detection of myxoma viruses encoding a defective M135R gene from clinical cases of myxomatosis; possible implications for the role of the M135R protein as a virulence factor. Virol. J. 2010, 7, e7.
202. Dalton, K.P.; Nicieza, I.; Baragaño, A.; Alonso, J.M.M.; Parra, F. Molecular characterisation of virulence graded field isolates of myxoma virus. Virol. J. 2010, 7, e49.
203. Muller, A.; Silva, E.; Abrantes, J.; Esteves, P.J.; Ferreira, P.G.; Carvalheira, J.C.; Nowotny, N.; Thompson, G. Partial sequencing of recent Portuguese myxoma virus field isolates exhibits a high degree of genetic stability. Vet. Microbiol. 2010, 140, 161-166.
204. Davison, A.J.; Moss, B. Structure of vaccinia virus early promoters. J. Mol. Biol. 1989, 2210, 749-769.
205. Davison, A.J.; Moss, B. Structure of vaccinia virus late promoters. J. Mol. Biol. 1989, 210, 771-784.
206. Esposito, J.J.; Sammons, S.A.; Frace, A.M.; Osborne, J.D.; Olsen-Rasmussen, M.; Zhang, M.; Govil, D.; Damon, I.K.; Kline, R.; Laker M., et al. Genome sequence diversity and clues to the evolution of Variola (smallpox) virus. Science 2006, 313, 807-812.
207. Hatcher, E.L.; Hendrickson, R.C.; Lefkowitz, E.J. Identification of nucleotide-level changes impacting gene content and genome evolution in orthopoxviruses. J. Virol. 2014, 88, 13651-13668.
208. Cooke, B.D.; Fenner, F. Rabbit haemorrhagic disease and the biological control of wild rabbits, Oryctolagus cuniculus, in Australia and New Zealand. Wildl. Res. 2002, 29, 689-706.
209. Di Giallonardo, F.; Holmes, E.C. Viral biocontrol: Grand experiments in disease emergence and evolution. Trend Microbiol. 2015, 23, 83-90.